Plasma and urinary sex hormones are differently related to lipids in healthy postmenopausal women

Maturitas

Volumn 44, Issue 3, 2003, Pages 181-187

  Ossewaarde, Marlies E ^a   Bots, Michiel L ^a   Van Der Schouw, Yvonne T ^a   Thijssen, Jos H H ^a   Westerveld, H Tineke ^a   De Jong, Frank H ^b   Grobbee, Diederick E ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

Endogenous; Estrone; Lipids; Obesity; Plasma; Urine

Indexed keywords

ESTRONE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPID; LOW DENSITY LIPOPROTEIN CHOLESTEROL; SEX HORMONE; TRIACYLGLYCEROL; VERY LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ADULT; AGED; ARTICLE; BODY MASS; CLINICAL ARTICLE; CONTROLLED STUDY; ESTRONE BLOOD LEVEL; FEMALE; HORMONE URINE LEVEL; HUMAN; LEAN BODY WEIGHT; LIPID BLOOD LEVEL; MEASUREMENT; OBESITY; POSTMENOPAUSE; RADIOIMMUNOASSAY; SMOKING; URINALYSIS;

EID: 0037470713     PISSN: 03785122     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0378-5122(02)00338-9     Document Type: Article

References (34)

1. Matthews K.A., Wing R.R., Kuller L.H., Meilahn E.N., Plantinga P. Influence of the perimenopause on cardiovascular risk factors and symptoms of middle-aged healthy women. Arch. Intern. Med. 154:1994;2349-2355.
2. Kannel W.B., Hjortland M.C., McNamara P.M., Gordon T. Menopause and risk of cardiovascular disease: the Framingham study. Ann. Intern. Med. 85:1976;447-452.
3. Witteman J.C., Grobbee D.E., Kok F.J., Hofman A., Valkenburg H.A. Increased risk of atherosclerosis in women after the menopause. Br. Med. J. 298:1989;642-644.
4. Fukami K., Koike K., Hirota K., Yoshikawa H., Miyake A. Perimenopausal changes in serum lipids and lipoproteins: a 7-year longitudinal study. Maturitas. 22:1995;193-197.
5. van Beresteijn E.C.H., Korevaar J.C., Huijbregts P.C., Schouten E.G., Burema J., Kok F.J. Perimenopausal increase in serum cholesterol: a 10-year longitudinal study. Am. J. Epidemiol. 137:1993;383-392.
6. Jensen J., Nilas L., Christiansen C. Influence of menopause on serum lipids and lipoproteins. Maturitas. 12:1990;321-331.
7. Bonithon K.C., Scarabin P.Y., Darne B., Malmejac A., Guize L. Menopause-related changes in lipoproteins and some other cardiovascular risk factors. Int. J. Epidemiol. 19:1990;42-48.
8. Knopp R.H. Cardiovascular effects of endogenous and exogenous sex hormones over a woman's lifetime. Am. J. Obstet. Gynecol. 158:1988;1630-1643.
9. O'Brien T., Nguyen T.T. Lipids and lipoproteins in women. Mayo Clin. Proc. 72:1997;235-244.
10. Pasquali R., Casimirri F., Pascal G., et al. Influence of menopause on blood cholesterol levels in women: the role of body composition, fat distribution and hormonal milieu. Virgilio Menopause Health Group. J. Intern. Med. 241:1997;195-203.
11. Masarei J.R., Armstrong B.K., Skinner M.W., et al. HDL-cholesterol and sex hormone status [letter]. Lancet. 1:1980;208.
12. Kuller L.H., Gutai J.P., Meilahn E., Matthews K.A., Plantinga P. Relationship of endogenous sex steroid hormones to lipids and apoproteins in postmenopausal women. Arteriosclerosis. 10:1990;1058-1066.
13. Soler J.T., Folsom A.R., Kaye S.A., Prineas R.J. Associations of abdominal adiposity, fasting insulin, sex hormone binding globulin, and estrone with lipids and lipoproteins in postmenopausal women. Atherosclerosis. 79:1989;21-27.
14. Berge L.N., Bonaa K.H., Nordoy A. Serum ferritin, sex hormones, and cardiovascular risk factors in healthy women. Arterioscler. Thromb. 14:1994;857-861.
15. Cauley J.A., Gutai J.P., Kuller L.H., Powell J.G. The relation of endogenous sex steroid hormone concentrations to serum lipid and lipoprotein levels in postmenopausal women. Am. J. Epidemiol. 132:1990;884-894.
16. Barrett C.E., Goodman-Gruen D. Prospective study of endogenous sex hormones and fatal cardiovascular disease in postmenopausal women. Br. Med. J. 311:1995;1193-1196.
17. Falk R.T., Gail M.H., Fears T.R., et al. Reproducibility and validity of radioimmunoassays for urinary hormones and metabolites in pre- and postmenopausal women. Cancer Epidemiol. Biomarkers Prev. 8:1999;567-577.
18. Lonning P.E., Dowsett M., Jacobs S., Schem B., Hardy J., Powles T.J. Lack of diurnal variation in plasma levels of androstenedione, testosterone, estrone and estradiol in postmenopausal women. J. Steroid Biochem. 34:1989;551-553.
19. Noel C.T., Reed M.J., Jacobs H.S., James V.H. The plasma concentration of oestrone sulphate in postmenopausal women: lack of diurnal variation, effect of ovariectomy, age and weight. J. Steroid Biochem. 14:1981;1101-1105.
20. Grodin JM, Siiteri PK, MacDonald PC. Source of estrogen production in postmenopausal women, J Clin Endocrinol Metab 1973.
21. Cauley J.A., Gutai J.P., Kuller L.H., Powell J.G. Reliability and interrelations among serum sex hormones in postmenopausal women. Am. J. Epidemiol. 133:1991;50-57.
22. Baanders-van Halewyn E.A., Blankenstein M.A., Thijssen J.H., de Ridder C.M., de Waard F.A. Comparative study of risk factors for hyperplasia and cancer of the endometrium. Eur. J. Cancer Prev. 5:1996;105-112.
23. Friedewald W.T., Levy R.I., Fredrickson D.S. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin. Chem. 18:1972;499-502.
24. Knuiman J.T., Hautvast J.G., van der Heyden L., et al. A multi-centre study on completeness of urine collection in 11 European centres. I. Some problems with the use of creatinine and 4-aminobenzoic acid as markers of the completeness of collection. Hum. Nutr. Clin. Nutr. 40:1986;229-237.
25. Brunner D., Weisbort J., Meshulam N., et al. Relation of serum total cholesterol and high-density lipoprotein cholesterol percentage to the incidence of definite coronary events: twenty-year follow-up of the Donolo-Tel Aviv Prospective Coronary Artery Disease Study. Am. J. Cardiol. 59:1987;1271-1276.
26. Bass K.M., Newschaffer C.J., Klag M.J., Bush T.L. Plasma lipoprotein levels as predictors of cardiovascular death in women. Arch. Intern. Med. 153:1993;2209-2216.
27. Livshits G., Weisbort J., Meshulam N., Brunner D. Multivariate analysis of the twenty-year follow-up of the Donolo-Tel Aviv Prospective Coronary Artery Disease Study and the usefulness of high density lipoprotein cholesterol percentage. Am. J. Cardiol. 63:1989;676-681.
28. Kannel W.B., Castelli W.P., Gordon T., McNamara P.M. Serum cholesterol, lipoproteins, and the risk of coronary heart disease. The Framingham study. Ann. Intern. Med. 74:1971;1-12.
29. Rouffy J. Interference with lipid metabolism by various antihypertensive agents: facts and hypotheses. Arch. Mal. Coeur Vaiss. 80:1987;43-46. Spec No 43-46.
30. Baker L.L., Criqui M.H. High- and low-density lipoprotein cholesterol: correlates in an older population. Prev. Med. 14:1985;155-164.
31. Svendsen O.L., Hassager C., Christiansen C. Relationships and independence of body composition, sex hormones, fat distribution and other cardiovascular risk factors in overweight postmenopausal women. Int. J. Obes. Relat. Metab. Disord. 17:1993;459-463.
32. Tchernof A, Labrie F, Belanger A et al. P. Relationships between endogenous steroid hormone, sex hormone-binding globulin and lipoprotein levels in men: contribution of visceral obesity, insulin levels and other metabolic variables, Atherosclerosis 1997;133:235-244.
33. Howard B.V. Obesity, lipoproteins, and heart disease. Proc. Soc. Exp. Biol. Med. 200:1992;202-205.
34. Thijssen J.H., Veeman W. A gas chromatographic method for the measurement of small amounts of estrogens in urine. Steroids. 11:1968;369-387.